Lumida
/AHR
⌘K
American Healthcare REIT Inc

American Healthcare REIT Inc

AHR
$57.16USD+1.01%+0.57 today

MARKET CAP

685.8M

P/E (TTM)

61.5x

FWD P/E

373.6x

DAY RANGE

$57 – $58

52W RANGE

$37
$58

AI Summary

Stalk
StalkMedium

AHR remains in a Stage 2 advancing uptrend confirmed by a strong Momentum Breakout, but price is extended above rising EMAs with visible exhaustion and extreme overbought readings. The medium-term bias stays bullish, so we recommend deferring buys (Stalk) until pullbacks into the rising 9 and 21 EMA support zone are favorably accepted rather than buying into the current extension.

  • Normalized FFO up 31.6% YoY to $0.50/share in Q1 2026
  • Same-store NOI grew 12.1% for ninth straight quarter of double-digit gains
  • Negative earnings yield and weak book-to-price suggest overvaluation
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

American Healthcare REIT, Inc. (NYSE: AHR) specializes in healthcare real estate, focusing on investments in senior housing and integrated healthcare facilities, such as Trilogy. The company is strategically positioned to benefit from an aging population and favorable supply-demand dynamics in the senior living market. By leveraging robust partnerships with regional operators, AHR is able to provide high-quality care and maintain strong occupancy levels, reinforcing its competitive edge.

Bull says

  • Normalized FFO up 31.6% YoY to $0.50/share in Q1 2026
  • Same-store NOI grew 12.1% for ninth straight quarter of double-digit gains
  • Acquisition pipeline exceeds $650M, supporting continued portfolio growth
  • Aging baby-boomer population drives rising senior housing demand
  • Net debt/EBITDA improved to 3.0x, boosting financial resilience amid rising rates
  • Strong growth and momentum factors with low price volatility

Bear says

  • Negative earnings yield and weak book-to-price suggest overvaluation
  • Medicare/Medicaid rate variability (2.4% hike forecast) threatens margins
  • Elevated short interest reflects market skepticism on growth outlook
  • Integration risk from undermanaged acquisitions may hinder execution
  • Seasonal occupancy dips (e.g., summer elective surgery lull) could hit revenues
  • Low profitability factor raises concerns over sustainable returns

Investment themes with AHR

Residential REITs +0.00%

Stable income from diversified rental housing portfolios

WELL · PSA · VTR

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-14-2026neutral

Transcript signals

Bull points

  • American Healthcare REIT's first quarter 2026 earnings conference call.
  • increased 2026 guidance
  • Year to date, we have closed $249.2 million of new acquisitions, all within our shop segment.

Bear points

  • the average Medicaid mix being 60, 70% of a building, it's really hard for it to pencil out from a development perspective.
  • The problem is it's not an unlimited amount of dollars and it's not a major amount of dollars either.
  • In some ways, it gets a little trickier because the Medicare growth rate is decelerating a little bit. That number is triggered off of inflation. As inflation comes down, that number comes down as well.
Read full transcript analysis ›